Linked e-resources
Details
Table of Contents
Contributors; Brain Tumor Imaging; 1 Introduction; 1.1 Overview; 2 Clinical Management; 3 Glial Tumors; 3.1 Focal Glial and Glioneuronal Tumors Versus Diffuse Gliomas; 3.2 Low-Grade Versus High-Grade Gliomas; 3.3 Astrocytomas Versus Oligodendroglial Tumors; 3.4 Low-Grade Glioma (WHO Grade II); 3.4.1 Diffuse Astrocytoma (WHO Grade II); 3.4.2 Oligodendroglioma and Oligoastrocytoma (WHO Grade II); 3.5 Anaplastic Glioma (WHO Grade III); 3.5.1 Anaplastic Astrocytoma (WHO Grade III); 3.5.2 Anaplastic Oligodendroglioma and Oligoastrocytoma; 3.5.3 Gliomatosis Cerebri.
3.6 Glioblastoma (WHO Grade IV)4 Primary CNS Lymphomas; 5 Metastatic Tumors of the CNS; References; MR Imaging of Brain Tumors; 1 Introduction; 2 Brain Tumors in Adults; 2.1 Questions to the Radiologist; 2.2 Tumor Localization; 2.3 Tumor Malignancy; 2.4 Tumor Monitoring; 2.5 Imaging Protocol; Computer Tomography; 2.6 Case Illustrations; 3 Pediatric Brain Tumors; 3.1 Standard MRI; 3.2 Differential Diagnosis of Common Pediatric Brain Tumors; 3.3 Early Postoperative Imaging; 3.4 Meningeal Dissemination; 3.5 Follow-Up Examinations; References; MR Spectroscopic Imaging; 1 Methods.
1.1 Introduction to MRS1.2 Summary of Spectroscopic Imaging Techniques Applied in Tumor Diagnostics; 1.3 Partial Volume Effects Due to Low Resolution; 1.4 Evaluation of Metabolite Concentrations; 1.5 Artifacts in Metabolite Maps; 2 Tumor Metabolism; 3 Tumor Grading and Heterogeneity; 3.1 Some Aspects of Differential Diagnosis; 3.1.1 Using Sophisticated Analysis Schemes and/or Pattern Recognition Techniques; 4 Prognostic Markers; 5 Treatment Monitoring; References; MR Perfusion Imaging; 1 Key Points; 2 Methods; 2.1 Exogenous Tracer Methods.
2.1.1 Dynamic Susceptibility Contrast MRI2.1.2 Dynamic Contrast-Enhanced MRI; 2.2 Endogenous Tracer Methods: Arterial Spin Labeling; 3 Clinical Application; 3.1 General Aspects; 3.2 Pathophysiological Background: Neovascularization in Brain Tumors; 3.3 Differential Diagnosis of Tumors; 3.4 Tumor Grading and Prognosis; 3.5 Guidance for Biopsy and Radiation Therapy Planning; 3.6 Treatment Monitoring; References; Diffusion-Weighted Methods; 1 Methods; 2 Microstructural Changes; 3 Tumor Grading, Typing, and Heterogeneity; 4 Prognostic Marker; 5 Treatment Monitoring; Conclusion.
3.6 Glioblastoma (WHO Grade IV)4 Primary CNS Lymphomas; 5 Metastatic Tumors of the CNS; References; MR Imaging of Brain Tumors; 1 Introduction; 2 Brain Tumors in Adults; 2.1 Questions to the Radiologist; 2.2 Tumor Localization; 2.3 Tumor Malignancy; 2.4 Tumor Monitoring; 2.5 Imaging Protocol; Computer Tomography; 2.6 Case Illustrations; 3 Pediatric Brain Tumors; 3.1 Standard MRI; 3.2 Differential Diagnosis of Common Pediatric Brain Tumors; 3.3 Early Postoperative Imaging; 3.4 Meningeal Dissemination; 3.5 Follow-Up Examinations; References; MR Spectroscopic Imaging; 1 Methods.
1.1 Introduction to MRS1.2 Summary of Spectroscopic Imaging Techniques Applied in Tumor Diagnostics; 1.3 Partial Volume Effects Due to Low Resolution; 1.4 Evaluation of Metabolite Concentrations; 1.5 Artifacts in Metabolite Maps; 2 Tumor Metabolism; 3 Tumor Grading and Heterogeneity; 3.1 Some Aspects of Differential Diagnosis; 3.1.1 Using Sophisticated Analysis Schemes and/or Pattern Recognition Techniques; 4 Prognostic Markers; 5 Treatment Monitoring; References; MR Perfusion Imaging; 1 Key Points; 2 Methods; 2.1 Exogenous Tracer Methods.
2.1.1 Dynamic Susceptibility Contrast MRI2.1.2 Dynamic Contrast-Enhanced MRI; 2.2 Endogenous Tracer Methods: Arterial Spin Labeling; 3 Clinical Application; 3.1 General Aspects; 3.2 Pathophysiological Background: Neovascularization in Brain Tumors; 3.3 Differential Diagnosis of Tumors; 3.4 Tumor Grading and Prognosis; 3.5 Guidance for Biopsy and Radiation Therapy Planning; 3.6 Treatment Monitoring; References; Diffusion-Weighted Methods; 1 Methods; 2 Microstructural Changes; 3 Tumor Grading, Typing, and Heterogeneity; 4 Prognostic Marker; 5 Treatment Monitoring; Conclusion.